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Abstract
Multidrug resistance 2 (Mdr2), also called adenosine triphosphate-binding cassette B4 (ABCB4), is the transporter of 
phosphatidylcholine (PC) at the canalicular membrane of mouse hepatocytes, which plays an essential role for bile 
formation. Mutations in human homologue MDR3 are associated with several liver diseases. Knockout of Mdr2 results 
in hepatic inflammation, liver fibrosis and hepatocellular carcinoma (HCC). Whereas the pathogenesis in Mdr2−/− mice 
has been largely attributed to the toxicity of bile acids due to the absence of PC in the bile, the question of whether 
Mdr2 deficiency per se perturbs biological functions in the cell has been poorly addressed. As Mdr2 is expressed in 
many cell types, we used mouse embryonic fibroblasts (MEF) derived from Mdr2−/− embryos to show that deficiency of 
Mdr2 increases reactive oxygen species accumulation, lipid peroxidation and DNA damage. We found that Mdr2−/− MEFs 
undergo spontaneous transformation and that Mdr2−/− mice are more susceptible to chemical carcinogen-induced 
intestinal tumorigenesis. Microarray analysis in Mdr2−/− MEFs and cap analysis of gene expression in Mdr2−/− HCCs revealed 
extensively deregulated genes involved in oxidation reduction, fatty acid metabolism and lipid biosynthesis. Our findings 
imply a close link between Mdr2−/−-associated tumorigenesis and perturbation of these biological processes and suggest 
potential extrahepatic functions of Mdr2/MDR3.
Introduction
Multidrug resistance P-glycoproteins, Mdr2 in mouse and MDR3 
in human, are the choline-containing phospholipid phosphati-
dylcholine (PC) transporters that belong to the subfamily B4 
of ATP-binding cassette transporters (ABCB4) (1). In the liver, 
Mdr2/MDR3 are involved in the translocation of PC from the 
inner leaflet to the outer leaflet of the canalicular membrane 
of hepatocytes for direct extraction by bile acids (BA). BA and 
PC are essential components in the bile that form BA micelles 
to reduce the toxic detergent activity of BA for hepatocytes 
and cholangiocytes and to establish physiological bile flow. 
Mutations in the ABCB4 gene in human result in deficiency of 
PC in the bile, causing diseases including progressive familial 
intrahepatic cholestasis type 3 (PFIC3), intrahepatic cholestasis 
of pregnancy and low-phospholipid-associated cholelithiasis 
(2). A  constitutive Mdr2 knockout mouse has been generated, 
which successively develops liver inflammation, hepatic fibrosis 
and hepatocellular carcinoma (HCC) at late ages (3). The patho-
genesis in Mdr2−/− mice is commonly considered to be caused by 
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toxic BA in the biliary canaliculus, which damages hepatocytes 
and cholangiocytes and provokes liver inflammation. However, 
the contribution of ABCB4 deficiency to the development of the 
pathologies has been largely unknown.
The ABC transporters are integral membrane proteins. The 
plasma membrane displays an asymmetric arrangement of the 
various phospholipids, with PC and sphingomyelin enriched in 
the exoplasmic leaflet and the aminophospholipids phosphati-
dylserine and phosphatidylethanolamine in the cytosolic leaflet 
(4). MDR3 can influence lipid components at the plasma mem-
brane, as it has been shown that exogeneous MDR3 expression 
in HEK293 cells increased sphingomyelin and cholesterol enrich-
ment in lipid rafts (5). Moreover, expression of MDR3 alters lipid 
composition on the envelop of HIV vector, thus reducing viral 
infectivity (6). MDR3-mediated transport of PC at the cell mem-
brane results in the formation of lipid vesicles, which induces 
cholesterol diffusion from cell membrane (7). These observa-
tions suggest that Mdr2/MDR3 are not only the PC transporters 
for bile formation, but also play a role in the maintenance of 
lipid homeostasis. Indeed, a previous report showed associa-
tion of alterations in lipid metabolism and liver pathogenesis in 
Mdr2−/− mice (8).
Although hepatocytes are the major cell type in which Mdr2/
MDR3 are expressed, Mdr2/MDR3 mRNAs have been detected in 
many tissues such as adrenal glands, muscle, tonsil and spleen 
and various cell types including T and B lymphocytes, epithe-
lial cells and fibroblasts (9,10). In this study, we used mouse 
embryonic fibroblasts (MEF) isolated from Mdr2−/− embryos to 
investigate if Mdr2 deficiency impacts on other cell functions 
than bile formation. We found accumulated reactive oxygen 
species (ROS), increased lipid peroxidation and DNA damages 
in Mdr2−/− MEFs. These findings were corroborated by observa-
tions in Mdr2−/− liver. Our results imply that Mdr2 deficiency can 
contribute to liver diseases through perturbation of ROS homeo-
stasis and underscore possible extrahepatic functions of Mdr2.
Materials and methods
Animals
Mdr2−/− (FVB.129P2-Abcb4tm1Bor/J) and WT FVB/NCrl mice were obtained 
from The Jackson Laboratory. Mdr2−/− mice were first mated to WT mice 
to generate Mdr2−/+ animals. Intercrossing Mdr2−/+ animals gave rise to 
Mdr2−/− and Mdr2+/+ littermates. All the experiments were performed with 
age- and sex-matched Mdr2−/− and Mdr2+/+ littermates. For azoxymethane 
(AOM) and dextran sodium sulfate (DSS)-induced intestinal tumorigen-
esis, female mice were used. Experimental procedures were approved by 
Ethic Committee Paris Center and South in accordance with the French 
government regulations. Mice were bred in a pathogen-free environment 
at the Institut Pasteur animal facility in accordance with welfare criteria 
outlined in the ‘Guide for the Care and Use of Laboratory Animals’.
Cell culture
MEF and derivatives, established and extensively characterized by us at 
the Institut Pasteur during this study, were derived from Mdr2−/−, Mdr2−/+ 
and Mdr2+/+ littermate embryos on day 13.5 generated by intercrossing 
Mdr2−/+ mice. Spontaneously immortalized cell lines were established 
using 3T3 protocol as described (11). Three independent MEFs prepara-
tions were performed. The earliest frozen stocks of all cell lines have 
been stored in nitrogen containers at the Institut Pasteur. We have propa-
gated cells from frozen stocks of the original vials that were authenti-
cated by qPCR on the expression of Mdr2. The validation of the identity 
of cells at the earliest stocks or grown >20 passages was tested on regular 
basis. MEFs were cultured in Dulbecco’s modified Eagle medium (DMEM 
(1×)-glutaMAXTM-I supplemented with 10% fetal bovine serum, in 95% air 
and 5% CO2 atmosphere and humidified incubator at 37°C. To measure 
cell proliferation, MEFs were plated at a density of 2 × 104 cells into six-
well plates in triplicate. Cell numbers were determined using a Z1 Coulter 
Counter® (Beckman Coulter). To examine resistance to doxorubicin (Dox)-
induced apoptosis, 2 × 103 primary and immortalized MEFs were seeded 
into 96-well plates and treated with increasing doses of Dox for 2 h. Cell 
viability was measured with MTT assay.
Mdr2 cDNA was synthesized and cloned in pCMV6 by OriGene and sta-
bly transfected into Mdr2−/− MEFs by Lipofectamine 2000 (Life Technologies) 
followed by G418 selection.
RNA analysis
For qPCR, total RNA was isolated from cells, mouse livers and mouse intes-
tines with RNeasy minikit (Qiagen). 1 μg of RNA was reverse-transcribed 
using random primers and the cDNA Sythesis Kit (Life Technologies). The 
mean copy number of each gene from a triplicate determination was nor-
malized to the mean copy number of hypoxanthine-guanine phospho-
ribosyltransferase. The sequences of primers used for qPCR are: mouse 
Mdr2 5′-GAGCAAAGTCCAGGTCTGC-3′, 5′-TGCTGCCTAGTTCAAAGTCG-3′; 
mouse Mdr1a 5′-CAACATCCACCAGTTCATCG-3′, 5′-AATGTGAGGCTGT 
CTGACGA-3′; mouse Mdr1b 5′-tgggtgcatacaaccagtgt-3′, 5′-tcagccccataacca-
gaaag-3′. The sequences of hypoxanthine-guanine phosphoribosyltrans-
ferase were published previously (12).
For microarray experiment, 50 ng of total RNA from MEFs was reverse 
transcribed and amplified using the Ovation Pico WTA System v2 (Nugen 
Technologies, Inc. #3302–12), cDNA was biotin labeled before hybridiza-
tion on Affymetrix Genechip Mouse Gene 2.0 ST Array. Two independent 
WT and three independent Mdr2−/− primary or immortalized MEF clones 
were profiled via microarrays according to the ‘Target Preparation for 
Affymetrix GeneChip® Eukaryotic Array Analysis’ protocol. Microarray 
data are available through the Gene Expression Omnibus (GEO) database 
under accession number GSE72615.
CAGE libraries (for Cap Analysis of Gene Expression) with total RNA 
extracted from WT or Mdr2−/− livers were constructed following the proto-
col reported previously (13). About 5 μg of total RNA was used to synthesize 
cDNA with random primers. Full-length cDNAs were biotinylated and cap-
tured by streptavidin-coated magnetic beads. The cDNAs were released 
from cap-trapped RNAs, ligated to 5′ linkers including barcode sequences, 
and digested with EcoP15I. CAGE libraries were sequenced with single-end 
reads of 50 bp on the Illumina HiSeq 2000 platform. CAGE data are avail-
able through GEO database under accession number GSE60982.
Microarray and CAGE data analyses
After quality assessment and normalization of the arrays, gene-level 
expression values were derived from the CEL file probe-level hybridization 
intensities using the model-based Robust Multichip Average algorithm. 
The estimated false discovery rate (FDR) of the local pooled error test was 
calculated using the BH approach. The list of deregulated genes in biologi-
cal processes analyzed using the Gene Ontology is available upon request.
For CAGE data analysis, differentially expressed genes between tumor 
versus normal were identified using a Bayesian T-test (14) on the normal-
ized data. For each P value, the Benjamini–Hochberg procedure was used 
Abbreviations 
AOM azoxymethane 
BA bile acid 
CAGE Cap Analysis of Gene Expression 
DSS dextran sodium sulfate
Dox doxorubicin 
FDR false discovery rate
HCC hepatocellular carcinoma 
MDA malondialdehyde 
MEF mouse embryonic fibroblasts 
Mdr2 multidrug resistance 2
PC phosphatidylcholine 
PPARa peroxisome proliferator-activated receptor a 
ROS reactive oxygen species 
SCC Spearman Correlation Coefficient
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to calculate the FDR to avoid the problem of multiple testing (15). The sig-
nificant genes were selected using 0.05 as threshold for the FDR.
For each pair of genes we computed the Spearman Correlation 
Coefficient (SCC) obtaining a correlation coefficient matrix. We estimated 
the SCC significance for each pair of genes by computing t-statistics of 
each SCC value and then using Student’s t-test distribution to estimate 
the P value. To control the number of false positives owing to the multi-
ple hypotheses test problem, we estimated the degrees of freedom of the 
t-test distribution from the data by fitting the parameters of a Student’s 
t-location-scale distribution to the t statistics computed for all the genes 
pairs. We estimated the parameters by minimizing the squared error 
between the theoretical and the empirical distribution. We then generated 
a network by connecting two genes if the associated SCC was significant 
(corrected P < 0.05). From the total network, we extracted the subnetwork 
of the significant differentially expressed genes and the groups of densely 
interconnected genes (i.e. communities) were detected via the Walktrap 
Algorithm by Pons and Latapy (16). This algorithm uses a hierarchical 
agglomerative method and the distance between two nodes is defined in 
terms of random walks. The idea is that shorts random walks tend to stay 
in the same communities. We assessed that 40% of the identified com-
munities are enriched for a specific biological function by Gene Ontology 
analysis performed using the Database for Annotation, Visualization and 
Integrated Discovery (DAVID) Functional Annotation Clustering tool (17). 
The list of Gene Ontology enrichment for each of the community is avail-
able upon request.
Protein analysis
1.5 × 105 MEFs were seeded into six-well plates and synchronized by incu-
bation in 0.5% fetal bovine serum in DMEM for 72 h. Synchronized cells 
were stimulated by 10% fetal bovine serum in DMEM. Cellular extracts 
were prepared at indicated times post-stimulation and analyzed by immu-
noblotting. The following primary antibodies were used: cyclin D1 (sc-450), 
cyclin A (sc-751), β-actin (Sigma-Aldrich), caspase-3 (Cell Signaling), HP1α 
(Euromedex), Akt and phospho-Akt (Cell Signaling). Mitotic cells were ana-
lyzed by immunofluorescence with antibodies against phosphorylated 
H2AX on Ser139 and 53BP1 (Cell Signaling). Immunohistochemistry (IHC) 
with antibodies against phosphorylated H2AX on Ser139 and 53BP1 was 
performed with 4-month-old liver as described previously (18).
Measurement of ROS and malondialdehyde (MDA)
Intracellular ROS contents were measured by flow cytometry analysis using 
2,7-dichlorodihydrofluorescein diacetate dye (H2DCFDA, Life Technologies) 
as described previously (19). Briefly, MEFs were treated for 1 h with 0.1 mM 
H2O2, then allowed to recover in fresh media and harvested after 1 and 6 h. 
Then cells were incubated in pre-warmed Hanks’ balanced salt solution 
in the presence of 10 µM H2DCFDA and incubated 1 h at room tempera-
ture. Dye loading buffer was then removed and replaced by pre-warmed 
complete growth media. Cells were incubated for 30 min at 37°C to allow 
H2DCFDA oxidation generating 2,7-dichlorofluorescein (DCF), a fluores-
cent compound. ROS accumulation was analyzed using a MACSQuant® 
(Miltenyi Biotec) flow cytometer and FlowJo software.
The end product of lipid peroxidation MDA was measured using Lipid 
Peroxidation Assay Kit (Abcam). Cells or liver tissues were homogenized 
in MDA lysis buffer. Insoluble materials were removed by centrifuga-
tion. Supernatant was used for the Colorimetric Assay to quantify MDA 
amounts according to the Manufacturer’s Protocol.
Cell transformation assays and tumorigenesis
For focus assay, MEFs were seeded at 150, 300 or 600 cells/well in six-well 
plates. After 2 weeks, cells were stained with crystal violet and colonies 
more than 2 mm in diameter were counted under a Nikon-Eclipse TS100 
light microscope. The experiments were repeated twice with two inde-
pendent MEFs preparations. For soft agar assay, cells were resuspended 
in 0.3% agarose in DMEM at a density of 5 × 104 cells/well in six-well plates 
and plated in triplicate onto solidified 0.6% agarose-containing medium. 
Cells grew for 4 weeks and were supplemented with fresh media two 
times a week. Colonies were stained by 0.005% crystal violet and counted 
using a light microscope. The experiments were repeated twice with dif-
ferent MEFs preparations. For in vivo tumorigenesis assays, 5 × 106 cells 
were implanted s.c. into each flank of five 8-week-old female athymic 
BALB/c mice (Charles River Laboratories). Tumor growth was monitored 
with a caliper for 3 weeks. No tumor developed in control group during 
the period of observation of 10 weeks. The experiment was repeated once.
Intestinal tumor induction
Intestinal tumors were induced by AOM and DSS according to a previ-
ous report (20). 6- to 8-week-old female mice (Mdr2+/+ and Mdr2−/− litter-
mates on FVB background) were injected intraperitoneally with 10 mg/kg 
body weight AOM (Sigma-Aldrich) and exposed seven days later to three 
cycles of 2.5% of Dextran Sulfate 40 Sodium (A3261, AppliChem, average 
molecular weight 40 000 g/mol) administrated in the drinking water for 
7  days, followed by 14  days of regular water. Mice were killed after the 
last cycle. Intestines were removed from mice and fixed as ‘Swiss rolls’ in 
4% paraformaldehyde. Tumor scoring and histopathological analysis were 
described previously (21).
Results
Deficiency of Mdr2 in MEFs increases cell 
proliferation and resistance to Dox-induced 
apoptosis
We isolated WT and Mdr2−/− MEFs derived form Mdr2+/+ and 
Mdr2−/− littermate embryos. After confirming expression of 
Mdr2 mRNA by qPCR in WT MEFs (Figure 1A), primary WT and 
Mdr2−/− cells were subjected to passages using the 3T3 protocol 
to obtain spontaneously immortalized cell lines. No difference 
in growth and senescence kinetics was observed between pri-
mary Mdr2+/+, Mdr2+/− and Mdr2−/− cells (Figure  1B). When pri-
mary WT and Mdr2-/- cells were subjected to serum starvation 
for 72 h followed by serum addition, expression of the cell cycle 
regulators cyclin D1 and cyclin A  displayed similar intensity 
and kinetics in response to serum stimulation (Figure 1C, left 
panel). In sharp contrast, immortalized Mdr2−/− cells showed 
distinct proliferation profiles. They grew significantly faster 
than Mdr2+/+ MEFs, whereas Mdr2+/− cells exhibited an interme-
diate growth rate (Figure 1D). Accordingly, in Mdr2−/− cells, the 
kinetics of induction of cylcin D1 and cyclin A was drastically 
advanced in response to serum stimulation, and the levels of 
the induction were greatly augmented (see Figure  1C, right 
panel).
To confirm that Mdr2 deficiency was directly involved in 
the phenotype, we re-expressed Mdr2 in primary Mdr2−/− MEFs 
at early passages (Figure  1E) and assessed the effect of exog-
enous Mdr2 expression on cyclin D1, cylcin A and cell growth. 
Continuous passage of Mdr2-restored MEFs readily gave rise to 
established 3T3 cell lines. Restoration of Mdr2 in Mdr2−/− MEFs 
delayed cyclin D1 and cyclin A  induction and decreased their 
levels of expression (Figure 1F). In addition, exogenous expres-
sion of Mdr2 significantly decelerated cell growth (Figure 1G).
As deregulation of cell proliferation is frequently associated 
with deregulation of cell death, we next examined the effects of 
Mdr2 deficiency on apoptosis. Treatment with Dox, an apopto-
sis inducer with a broad-spectrum antibiotic activity, caused a 
decrease of cell viability in both primary WT and Mdr2−/− MEFs 
in a dose-dependent manner with similar kinetics (Figure 1H). 
In contrast, immortalized Mdr2−/− MEFs were more resistant to 
Dox-induced apoptosis, showing significant higher viability 
than WT counterparts when treated with 0.5 μM Dox or higher 
doses (Figure 1I and J). While analysis by immunoblotting readily 
revealed cleaved caspase-3 in WT cells treated with Dox, indica-
tive of the activation of this critical executioner of apoptosis, the 
cleaved form of caspase-3 was barely detectable in Mdr2−/− MEFs 
(Figure 1K). As a previous report showed that moderate increase 
in mRNA levels of Mdr1a and Mdr1b in murine breast cancer can 
cause Dox resistance (22), we assessed expression of Mdr1a and 
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Figure 1. Loss of Mdr2 increases cell proliferation and resistance to apoptosis. (A) Mdr2 mRNA expression in Mdr2+/+, Mdr2−/+ and Mdr2−/− MEFs at passage 3 by qPCR. 
(B) Primary Mdr2+/+, Mdr2−/+ and Mdr2−/− cell proliferation on a 3T3 protocol. Data shown are representative of cell proliferation of three independent MEF preparations 
from littermate embryos. (C) Primary and immortalized WT and Mdr2−/− cells were synchronized by serum starvation and stimulated by 10% serum. Cell lysates were 
prepared at the indicated time after stimulation and analyzed by immunoblotting. Similar results were obtained with two other independent clones. (D) Increased cell 
proliferation in immortalized Mdr2−/− cells. Equal numbers of spontaneously immortalized WT and Mdr2−/− MEFs were plated in triplicate. Cell numbers were deter-
mined during 5 days. Data presented are the mean values ± standard deviation obtained from three independent cell cultures. The experiments were repeated with two 
other independent clones. The asterisk indicates significant difference between WT and KO. **P < 0.005, Student’s test. KO: Mdr2 knockout, HE: Mdr2 heterozygote. (E) 
Ectopic expression of Mdr2 in Mdr2−/− MEFs. Mdr2 mRNA expression in WT MEFs, Mdr2−/− MEFs transfected with empty vector and Mdr2−/− MEFs transfected with vector 
expressing Mdr2 by qPCR. (F) Reduced cyclin D1 and cyclin A expression in Mdr2−/− cells after introduction of Mdr2 was detected by immunoblotting with anti-cyclin 
D1 and anti-cyclin A antibodies. (G) Growth curve of immortalized vector-transfected Mdr2−/− MEFs, Mdr2-transfected Mdr2−/− MEFs and WT MEFs. Equal numbers of 
cells were plated in triplicate at the beginning of the experiments. Cell numbers were determined every day for a total of 6 days. Data presented are the mean values 
± standard deviation obtained from three independent cell cultures. The experiments were repeated with two other independent Mdr2-transfected Mdr2−/− pools. 
**P < 0.005, Student’s test. Primary (H) and immortalized (I) WT and Mdr2−/− MEFs were treated with increasing doses of Dox. Cell viability was analyzed by MTT assay. 
Data presented are the mean values ± standard deviation obtained from three independent experiments. The experiments were repeated with two other independent 
preparations of MEFs. a.u.: arbitrary unit. (J) Immortalized MEFs were treated with 0.5 μM Dox for different times. Cell viability was examined at indicated time points 
by MTT assay. *P < 0.05, Student’s test. KO: Mdr2 knockout cells. (K) Proteins were extracted from immortalized MEFs without treatment or with treatment of 0.5 μM Dox 
for 12 h and analyzed by immunoblotting with anti-caspase-3 antibody. NS: non-specific. 
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Mdr1b in immortalized Mdr2−/− MEFs by qPCR. There was a trend 
but not significant increase in Mdr1a and Mdr1b expression in 
Mdr2−/− cells (Supplementary Figure 1, available at Carcinogenesis 
Online). Together, these results demonstrate that Mdr2 defi-
ciency can increase cell proliferation as well as resistance to 
Dox-induced apoptosis.
Accumulation of ROS and increased lipid 
peroxidation in immortalized Mdr2−/− MEFS
To gain insight into the impact of Mdr2 deficiency on gene 
expression at the whole genome level, we performed cDNA 
microarray of primary and immortalized Mdr2−/− and WT cells 
to identify genes differentially expressed. As expected, primary 
Mdr2−/− and WT cells exhibited undistinguishable expression 
profile. In contrast, 827 probe sets were revealed differentially 
expressed between WT and immortalized Mdr2−/− cells with FDR 
< 0.1% as the criterion for differential expression. Pathway anal-
ysis using the Gene Ontology evidenced deregulation of genes 
involved in different biological processes. These include regu-
lation of cell proliferation, positive regulation of biological pro-
cesses, lipid metabolic process, regulation of cell differentiation, 
defense response, lipid biosynthetic process, oxidation reduc-
tion and fatty acid metabolism (Supplementary Tables 1 and 2, 
available at Carcinogenesis Online), which have been previously 
identified in Mdr2−/− liver (8,23,24). Furthermore, in agreement 
with Katzenellenbogen et al. (23), deregulation of expression of 
Jun, MCM4, MCM7 and Pparg involved in DNA replication was 
also observed in Mdr2−/− MEFs (Supplementary Table 3, available 
at Carcinogenesis Online).
Since ROS acts as critical signaling molecules in cell pro-
liferation and survival, we set up to measure ROS production 
in immortalized MEFs. Cells were incubated with the probe 
H2DCFDA whose intracellular oxidation into the green fluores-
cein derivative 2,7-dichlorofluorescein (DCF) served as indicator 
of ROS formation (25). Analysis of the percentage of ROS-positive 
cells was carried out by flow cytometry. As shown in Figure 2A 
and B, immortalized Mdr2−/− cells displayed significantly higher 
levels of ROS than WT cells. We then treated cells with H2O2 for 
1 h and measured ROS-positive cells 1 and 6 h post-treatment. 
Both WT and Mdr2−/− cells showed high levels in ROS contents 
at 1 h point because of H2O2 addition (Figure 2A and B). Whereas 
WT cells almost eliminated all exogenous H2O2 6 h after treat-
ment, large amount of exogenous H2O2 still remained in Mdr2
−/− 
cells (Figure 2A and B), suggesting dysfunction of the antioxidant 
systems (26). These findings are correlated with microarray data 
showing deregulation of gene expression in biological process 
of oxidative reduction (see Supplementary Table 2, available at 
Carcinogenesis Online).
Oxidative stress occurs when the production of ROS exceeds 
their catabolism through either an increase in ROS levels or a 
decrease in the cellular antioxidant capacity. Oxidative stress 
results in direct or indirect ROS-mediated damage of lipids, pro-
teins and nucleic acids. ROS can react with polyunsaturated fatty 
acids of lipid membranes and induces lipid peroxidation (27). We 
thus measured the end product of lipid peroxidation MDA using 
colorimetric assay. As shown in Figure 2C, while no significant 
difference in the production of MDA was detected between pri-
mary WT and Mdr2−/− cells, immortalized Mdr2−/− cells produced 
significantly higher levels of MDA than WT counterparts, attest-
ing increased lipid peroxidation. ROS can cause double-strand 
DNA breaks, damaging DNA. The DNA damage-induced foci, 
marked by the histone variant H2AX phosphorylated on Ser139 
(γH2AX) and the recruitment of chromatin-associated genome 
caretakers such as p53-binding protein 1 (53BP1), represent 
sites of DNA breaks. Analysis by immunofluorescence detected 
numerous positive foci of γH2AX and 53BP1 in the nucleus of 
Mdr2−/− cells in contrast to few foci in WT cells (Figure 2D), indic-
ative of DNA damage in Mdr2−/− cells.
Increased lipid peroxidation and DNA damage in 
Mdr2−/− liver
We next wanted to investigate how Mdr2 deficiency affected lipid 
peroxidation in vivo. To address it, liver tissues were dissected 
from Mdr2−/− and WT mice at different ages and were subjected 
to quantification of MDA. As shown in Figure 3A, no difference 
was observed in MDA production between Mdr2−/− and WT livers 
from 2-week-old mice in which inflammation is not found yet 
(3). However, at 2-month-old and 4-month-old when inflamma-
tion is present, Mdr2−/− livers generated significant higher levels 
of MDA than WT counterparts (Figure  3A). Moreover, analy-
sis by IHC in the 4-month-old liver revealed six-fold increase 
of γH2AX-positive cells and 30-fold increase of 53BP1-positive 
cells in Mdr2−/− mice, showing significant difference compared 
to the WT liver (Figure  3B and C). This result is in agreement 
with previous report (28). DNA damage leads either to cell death 
or aberrant cell proliferation, which is one of the characteristics 
of cancer cells. In Mdr2−/− HCCs, we found dramatic increases 
in heterochromatin protein 1 isoform α (HP1α) abundance and 
Akt phosphorylation (Figure 3D). HP1α is overexpressed in many 
types of cancer and its high level expression is associated with 
rapid cell proliferation (29). Activation of the PI3K/Akt pathway 
results in a disturbance of control of cell growth and survival, 
which contributes to a competitive growth advantage.
To gain insight into alterations of gene expression at the 
whole-genome level in Mdr2−/− liver, CAGE was performed using 
liver samples from 6 WT mice and 31 Mdr2−/− mice (30). We ana-
lyzed CAGE data using a recently developed network-based 
approach (31). Briefly, we first identified differentially expressed 
genes (DEGs) between WT and Mdr2−/− mice for a total of 5844 
genes with FDR < 1% and 8653 with FDR < 5%. Due to the large 
number of significant genes, we used a co-expression net-
work approach to identify significantly dysregulated pathways 
in Mdr2−/− mice. To this end, we first generated a coexpression 
network from all the 37 WT and Mdr2−/− CAGE-seq expression 
profiles where genes are connected to each other if they are 
significantly coexpressed across the samples according to a 
correlation measure. We then extracted from the subnetwork 
containing only the significant DEGs and identified ‘commu-
nities’ of densely interconnected genes. Finally, we performed 
Gene Ontology enrichment analysis for each of the community. 
The top enriched Biological Process terms include ‘oxidation 
reduction’, ‘lipid biosynthetic process’ and ‘fatty acid metabolic 
process’ (Table 1), which is in accordance with previous report 
showing alterations of gene expression in lipid metabolism in 
the liver of Mdr2−/− mice (8,24). This network-based approach 
has the advantage to identify enriched biological processes 
with differentially expressed connected genes, even though 
the genes involved in the same biological process are not nec-
essarily the same when they are from different communities 
(Supplementary File 1, available at Carcinogenesis Online).
Collectively, ablation of Mdr2 results in increased levels of 
lipid peroxidation and DNA damage in the liver.
Spontaneous transformation of Mdr2-/- MEFs
To investigate direct impact of Mdr2 deficiency on cell trans-
formation, we tested anchorage-independent growth of Mdr2−/− 
MEFs at different passages on 3T3 protocol by soft agar assays. 
As shown in Figure 4A and B, no colony developed in neither WT 
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Figure 2. Reactive oxygen species (ROS) accumulation, increased lipid peroxidation and DNA damage in immortalized Mdr2−/− MEFs. (A, B) Cells were treated for 1 h with 
0.1 mM H2O2. ROS accumulation was analyzed before treatment or 1 and 6 h after treatment by flow cytometry. MFI: mean fluorescence intensity. *P < 0.05, **P < 0.005, 
Student’s test. (C) Primary and immortalized MEF extract was quantified for malondialdehyde (MDA) using Colorimetric Assay. **P < 0.005, Student’s test. (D) Analysis 
by immunofluorescence of immortalized WT and Mdr2−/− MEFs with antibodies against γH2AX and 53BP1.
Figure 3. Increased lipid peroxidation and DNA damage in the Mdr2−/− liver. (A) Liver extract was prepared from 2-week-old, 2-month-old and 4-month-old mice and 
quantified for malondialdehyde (MDA) by Colorimetric Assay. Three mice were used for each genotype. The data are presented as the MDA quantity per mg of liver 
weight. **P < 0.005, ***P < 0.0005, Student’s test. (B) Immunostaining with antibodies against γH2AX and 53BP1 on liver sections of WT and Mdr2−/− mice (n = 4). (C) Fold 
increase of γH2AX- and 53BP1-positive cells in Mdr2−/− mice over WT mice. (D) Immunoblotting analysis of expression of HP1α and Akt and phosphorylation of Akt in 
three WT livers and paired tumorous (T) and non-tumorous (NT) liver tissues from four Mdr2−/− mice.
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nor Mdr2−/− cells at passage 24, but strikingly, numerous colonies 
were detected at passage 38 in Mdr2−/− cells but not in WT cells. 
At passage 52, colonies were even more abundant in Mdr2−/− 
cells (Figure 4A). Quantification showed that about 100 and 170 
colonies were formed in a plate in Mdr2−/− cells at P38 and P52, 
respectively (Figure 4B). Next, cells at passage 38 were analyzed 
for the loss of contact inhibition by focus formation assays. Loss 
of Mdr2 markedly augmented colony formation (Figure 4C). The 
number of colonies per plate developed about 100 times more 
in Mdr2−/− cells than WT cells (Figure 4D). When injected s.c. into 
BALB/c nude mice, transformed Mdr2−/− MEFs induced tumor for-
mation in 10/10 mice, while no tumor developed in 10/10 mice 
injected with WT MEFs (Figure 4E and F). Together, these results 
indicate that deficiency of Mdr2 drives cell transformation.
Deletion of Mdr2 increases intestinal polyposis in a 
mouse model of colitis-associated cancer
To determine the in vivo effects of Mdr2 deficiency on cell trans-
formation in other tissues than the liver, we took advantage of 
the mouse model of AOM/DSS-induced intestinal tumorigenesis 
to investigate how Mdr2 affects the phenotype associated with 
AOM/DSS-induced cancer (32). The protocol of AOM/DSS admin-
istration was applied to Mdr2−/− mice and their Mdr2+/+ littermate 
control mice. Expression of Mdr2 mRNA in WT intestine was 
detectable by qPCR (data not shown). Because of enterohepatic 
circulation of bile, we first examined if the lack of phospholip-
ids in the bile had impact on the intestine in Mdr2−/− mice. As 
shown in Figure 5A–D, deletion of Mdr2 did not alter crypt-villus 
architecture of the small intestine. Regardless of genotype, all 
mice treated with AOM plus DSS developed tumors, which were 
mostly adenomas with high-grade dysplasia (Figure 5E and H). 
However, we observed a seven-fold increase in tumor incidence 
in the Mdr2−/− group (Figure 5I). We measured the sizes of polyps 
and showed that tumor sizes in Mdr2−/− group were larger than 
in the Mdr2+/+ group (Figure 5J). Precisely, there were proportion-
ally more tumors in Mdr2−/− mice with sizes superior to 5 mm 
than in WT mice (Figure 5J). Together, these results suggest that 
Mdr2 is important in both tumor initiation and tumor growth.
Discussion
Ablation of Mdr2 abolishes the PC transporter function causing 
bile defect-associated diseases including liver inflammation, 
hepatic fibrosis and HCC. It could also produce other patho-
genic properties that contribute to cell proliferation, survival 
Table 1. Representation of communities of the Mdr2−/− CAGE
ID N1 N2 Gene Ontology Biological process
1 259 19 GO:0055114 Oxidation reduction
1 259 12 GO:0008610 Lipid biosynthetic process
1 259 13 GO:0006631 Fatty acid metabolic process
1 259 4 GO:0006695 Cholesterol biosynthesis 
process
2 122 17 GO:0055114 Oxidation reduction
2 122 7 GO:0008202 Steroid metabolic process
3 200 32 GO:0055114 Oxidation reduction
3 200 7 GO:0009309 Amine biosynthetic process
4 127 11 GO:0010604 Positive regulation of macro-
molecule metabolic process
5 27 7 GO:0051301 Cell division
5 27 7 GO:0007049 Cell cycle
ID: the community identification number, N1: total number of genes in each 
community, N2: number of genes involved in the specified biological process, 
GO: Gene Ontology number.
Figure 4. Spontaneous transformation in Mdr2−/− MEFs. (A, B) Soft agar assay of WT and Mdr2−/− MEFs at different passages. Data presented are the mean values ± 
standard deviation obtained from three independent cell cultures. The experiments were repeated with two other clones from independent MEF preparations. The 
asterisk indicates significant difference between Mdr2−/− and WT cells at the same passage. ***P < 0.0005, Student’s test. (C, D) Focus formation assay of WT and Mdr2−/− 
MEFs at passage 38. Data presented are the mean values ± standard deviation obtained from three independent cell cultures. The experiments were repeated with two 
other clones from independent MEF preparations. The asterisk indicates significant difference between Mdr2−/− and WT cells when seeded with the same number of 
cells. ***P < 0.0005, Student’s test. (E, F) Tumorigenicity of transformed Mdr2−/− MEFs in athymic BALB/c mice. Data presented are the mean values ± standard deviation 
obtained from two flanks of five mice. The experiments were repeated once.
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and tumorigenesis. Here, we explored the phenotypic effects of 
Mdr2 deficiency in MEFs and in chemical carcinogen-induced 
intestinal tumor and showed that Mdr2 is necessary to main-
tain ROS homeostasis. Mdr2−/− MEFs produce high levels of ROS 
leading to increased lipid peroxidation and DNA damage. These 
cells display enhanced proliferation, resistance to Dox-induced 
apoptosis and spontaneously undergo transformation at late 
passages. The phenotypes in MEFs are correlated with the find-
ings in Mdr2−/− mice in which were observed enhanced levels of 
lipid peroxidation and DNA damage in the liver and increased 
susceptibility of carcinogen-induced tumor development in the 
intestine. These results contribute to the understanding of Mdr2 
actions in pathogenesis and raise questions of potential extra-
hepatic behaviors of MDR3 mutations in human.
Most of our understanding of how deletion of Mdr2 mediates 
its pathogenic activity has been derived from exploring the con-
sequences of the bile defect in the liver. Whereas hepatic inflam-
mation resulted from hepatocyte and cholangiocyte injury by 
toxic BAs in Mdr2−/− mice promotes production of ROS, oxidative 
DNA damage and reduced DNA repair (28), the contribution of 
Mdr2 deficiency to pathogenesis is poorly understood. Here, we 
show that deletion of Mdr2 enhances ROS production in MEFs, 
fostering lipid peroxidation and DNA damage. Questions remain 
as to how the transporter of PC acts mechanistically in the regu-
lation of ROS. Previous report showed that alterations in lipid 
metabolism and disruption of lipid homeostasis contribute to 
the pathogenesis and progression of cholestatic liver disease in 
Mdr2−/− mice (8). We hypothesize that disruption of lipid homeo-
stasis owing to Mdr2 deletion may represent the major event 
with consequences throughout pathways involved in ROS pro-
duction and catabolism and ROS-mediated damage repair (26). 
This view is supported by gene expression profiling in MEFs by 
microarray and in Mdr2−/− HCCs by CAGE that revealed significant 
expression changes in genes involved in oxidative reduction, 
lipid biosynthesis and fatty acid metabolism. Furthermore, our 
preliminary results suggest increased levels of lipids in Mdr2−/− 
cells even though we have not been able to identify which spe-
cific species of lipids were changed.
It has long been known that lipid can serve as second message 
for signal transductions and mediate an array of cellular response 
including inflammation, cell proliferation and apoptosis (33). 
Recently, specific species of PC have been identified as ligands for 
the nuclear receptors peroxisome proliferator-activated recep-
tor a (PPARa) and the liver receptor homolog 1 (LRH-1) (34,35), 
which not only are the key modulators of metabolism of glucose, 
lipid and BAs but also play important roles in carcinogenesis. 
Signaling through PPARa contributes to the upregulation of per-
oxisomal enzymes, such as acyl CoA oxidase, that produce the 
ROS H2O2 increasing oxidative stress. Besides, PPARa activation 
also leads to elevated hepatocellular proliferation and inhibition 
of apoptosis (36). Double knockout of Mdr2 and PPARa protected 
animals from chronic liver injury, resulting in reduced bile duct 
Figure 5. Deletion of Mdr2 increases intestinal tumor incidence. (A–H) Histological analysis of untreated and AOM/DSS treated intestines in WT and Mdr2−/− mice. (I) 
Total number of intestinal polyps was counted in 12 WT and 12 Mdr2−/− mice after AOM/DSS treatment. Compared to WT littermates, significant increase in poly number 
was observed in Mdr2−/− mice. ***P < 0.0005, Student’s test. (J) Mdr2 deficiency enhances tumor growth. The percentage of total number of polyps in 12 WT and 12 Mdr2−/− 
mice with size inferior to 2 mm, between 2 and 5 mm and superior to 5 mm is presented.
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proliferation and less fibrosis, whereas administration of PPARa 
activator fenofibrate in Mdr2−/− mice not only aggravated liver 
injury and fibrosis but also increased inflammation (8), demon-
strating a close link between PPARa-mediated signaling and the 
pathogenesis in Mdr2−/− mice. LRH-1 is a driving factor in devel-
opment and progression of cancer, especially colon, pancreatic 
and breast cancers, by promoting cell growth and proliferation 
(37–39). Thus nuclear receptor activation by PC ligands may con-
stitute a mechanism for lipid second message signaling functions 
in carcinogenesis. Moreover, endonuclear PC biosynthesis sup-
ports cell proliferation (40). Further study is needed to investigate 
the quantity, composition and cellular localization of PC species 
in Mdr2−/− cells and their impact on signal transductions.
Given the predominant and restricted functions of Mdr2 
in bile formation, most of the pathologic properties of Mdr2 
deficiency are thought to reflect toxic effects of BAs in the bile 
devoid of phospholipids. Indeed, previous work on the role of 
partial hepatectomy in HCC initiation and progression in Mdr2−/− 
mice suggests an accumulation of DNA double-strand breaks 
in the hepatocytes of the Mdr2−/− mice consequential to chronic 
inflammation (28). Though inflammation is a crucial force to 
promote increase in ROS accumulation in Mdr2−/− liver, we iden-
tified additional effects of Mdr2 deficiency that also contribute 
to oxidative stress. However, the fact that only immortalized 
but not primary Mdr2−/− MEFs showed increased proliferation, 
ROS accumulation and alterations in gene expression profile 
suggests that a ‘second hit’ event is necessary to sustain Mdr2 
deficiency-mediated oxidative stress. Our data provide evidence 
of broader functional roles of Mdr2, which is in line with previ-
ous report showing that Mdr2 is a modulator of glucose homeo-
stasis (41). Although we cannot exclude effects of abnormal bile 
composition in the increased propensity of Mdr2−/− mice to AOM/
DSS-induced intestinal tumorigenesis, AOM treatment alone 
showed development of few tumors in the intestine of Mdr2−/− 
mice similar to WT animals (data not shown), suggesting that 
bile components may not be a determinant factor of intestinal 
tumor development in this setting.
The identification of broader functions of the PC transport-
ers Mdr2/MDR3 may have impact on the appreciation of human 
diseases associated with MDR3 mutations. Although extrahe-
patic phenotypes have never been reported in patients harboring 
homozygous mutations in the MDR3 gene (42), analysis of potential 
effects of MDR3 defects in other tissues than the liver may provide 
full insight into disease pathogenesis. In particular, the question 
of whether the functions of immune cells are affected by MDR3 
mutations may be worth to be addressed, as these cells express 
the ABCB4 gene (10) and are key factors in mediating inflammatory 
response in the diseased liver caused by MDR3 mutations.
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